Sudden deafness

Current Opinion in Neurology

Volumn 19, Issue 1, 2006, Pages 1-3

  Mort, Dominic J ^a   Bronstein, Adolfo M ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; PENTOXIFYLLINE; STEROID; VALACICLOVIR;

AUDITORY SYSTEM; CLINICAL TRIAL; DISEASE ASSOCIATION; EDITORIAL; ENTEROVIRUS; HERPES ZOSTER; HERPES ZOSTER OTICUS; HISTOLOGY; HUMAN; MEASLES; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICAL SIGNIFICANCE; SUDDEN DEAFNESS; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 31644439999     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wco.0000196155.92856.a1     Document Type: Editorial

References (11)

1. Shikowitz MJ. Sudden sensorineural hearing loss. Med Clin North Am 1991; 75:1239-1250.
2. Van de Steene V, Kuhweide R, Vlaminck S, Casselman J. Varicella zoster virus: beyond facial paralysis. Acta Otorhinolaryngol Belg 2004; 58:61-66.
3. Callejo GFJ, Gil SE, Ventura MA, Algarra MJ. Presentation of 2 cases of sudden deafness in patients with sickle-cell anemia and trait (Spanish). Acta Otorrinolaringol Esp 2002; 53:371-376.
4. Chae SW, Cho JH, Lee JH, et al. Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome. J Laryngol Otol 2002; 116:291-293.
5. Lee H, Ahnc BA, Baloh RW. Sudden deafness with vertigo as a sole manifestation of anterior inferior cerebellar artery infarction. J Neurol Sci 2004; 222:105-107. This article illustrates how vertebrobasilary ischaemia can produce what might otherwise have been classified as ISHL, but for the demonstration that the patient was asymptomatic for contiguous acute infarction of a small area of pontine tegmentum.
6. Lee H, Baloh RW. Sudden deafness in vertebrobasilar ischemia: clinical features, vascular topographical patterns and long-term outcome. J Neurol Sci 2005; 228:99-104. An understanding of how often sudden deafness occurs in posterior circulation ischaemia had been hampered by a dearth of prospective data. This excellent study clarifies this issue, showing that it occurs more often than most neurologists would have thought. Moreover, it can precede the onset of symptoms of more extensive (usually AICA territory) infarction by up to days, in effect the herald of more extensive brainstem and cerebellar damage.
7. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980; 106:772-776.
8. Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensori-neural hearing loss. Laryngoscope 1984; 94:664-666.
9. Tucci DL, Farmer JC Jr, Kitch RD, Witsell DL. Treatment of sudden sensori-neural hearing loss with systemic steroids and valacyclovir. Otol Neurotol 2002; 23:301-308.
10. Westerlaken BO, Stokroos RJ, Dhooge IJ, et al. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol 2003; 112:993-1000.
11. Suckfull M. Hearing Loss Study Group. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002; 360:1811-1817.